AIM

#5038
AIM ImmunoTech Inc.
0.5800 USD
+7.57%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.5701
0.5840
Rango anual
0.5060
20.3500
Cambio diario
+7.57%
Variación mensual
-22.67%
Variación en los últimos 6 meses
-77.78%
Cambio anual
-93.18%
Cierres anteriores
0.5392
Abrir
0.5701
Bid
Ask
Mínimo
0.5701
High
0.5840
Volumen
22
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Noticias